OrthoPediatrics Q2 net loss holds at USD 7.2 million; revenue rises 15% to USD 70.5 million vs Q2 FY25
KIDS•Q2 results
- OrthoPediatrics Q2 revenue rose 15% to USD 70.5 million, driven by Trauma & Deformity growth.
- Net loss widened to USD 7.2 million, holding GAAP loss per share at USD 0.30.
- Adjusted EBITDA (non-GAAP) climbed 65% to USD 6.8 million; free cash flow used improved 78% to USD 3.1 million.
- Trauma & Deformity revenue jumped 26% to USD 52.6 million, while scoliosis revenue fell 9% to USD 16.9 million.
Full-year outlook
- Lifted full-year revenue outlook to USD 265 million-USD 269 million; expects about USD 25 million adjusted EBITDA (non-GAAP) and breakeven free cash flow.
Related News
Applied Optoelectronics SVP, Asia GM Joshua Yeh sells 4,715 common shares for $596,447.5
AAOI•
Booking Holdings CEO Middle East Conflict And Related Macroeconomic Developments Continue To Affect Travel Demand
BKNG•
